Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 35c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.80 -2.68%
Revenue Growth %: +17.5%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +17.5%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.04), $0.35 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $12.2 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Stifel downgrades Intuit to Hold on growth concerns, cuts target price
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
